Amacrine cells are a heterogeneous group of interneurons that form microcircuits with bipolar, amacrine and ganglion cells to process visual information in the inner retina. This study has characterized the morphology, neurochemistry and major cell types of a VIP-ires-Cre amacrine cell 
, and they have been broadly divided into narrow-, medium-, and wide-field types based on the lateral extent of their processes in the inner plexiform layer (IPL), as well as GABA-and glycinecontaining types (Kolb, Nelson, & Mariani, 1981; Vaney, 1990; Strettoi & Masland, 1996; MacNeil & Masland, 1998; Menger & Wässle, 2000; Lin & Masland, 2006) . This latter grouping has been recently revised with an additional glycine-and glutamate-containing amacrine cell type, named vesicular glutamate-transporter 3 (vGluT3) Johnson et al., 2004) . Additionally, in mouse retina 10% of the amacrine cells, named nGnG amacrine cells express the transcription factor Neurod6, and they do not contain GABA-, glycineor glutamate immunoreactivity (Kay, Voinescu, Chu, & Sanes, 2011b; Macosko et al., 2015) .
Several of these amacrine cell types, including the AII, cholinergic (ChAT; starburst), A17 (indoleamine-accumulating), vGluT3 and tyrosine hydroxylase (TH; dopaminergic) cells have been extensively studied and they constitute, as individual populations, a small percentage of the total number of amacrine cells (Brecha, Oyster, & Takahashi, 1984; Strettoi & Masland, 1996; Jeon, Strettoi, & Masland, 1998; Keeley et al., 2014) . The narrow-field AII amacrine cells are the most frequently occurring cell type in mouse and rabbit retina and they are estimated to make up 11% of the total amacrine cell population (Casini, Rickman, & Brecha, 1995; Jeon et al., 1998; MacNeil & Masland, 1998; Keeley et al., 2014) . In addition, these amacrine cell types have been well-studied physiologically, and they have distinct roles in the transformation of visual information in the inner retina (Witkovsky, 2004; Grimes, Zhang, Graydon, Kachar, & Diamond, 2010; Demb & Singer, 2012; Vaney, Sivyer, & Taylor, 2012; McMahon, Iuvone, & Tosini, 2014) . There are, however, large gaps in the understanding of the specific number and types of amacrine cells, and their connectivity and functional roles in the processing of visual information to shape bipolar input in the inner plexiform layer (IPL) and ganglion cell output to higher visual areas in the brain.
Multiple experimental approaches, including Golgi staining, photofilling, sparse genetic labeling, and intracellular labeling with Neurobiotin or fluorescent dyes have been used to define individual retinal cell types (Cajal, 1893; Kolb et al., 1981; MacNeil, Heussy, Dacheux, Raviola, & Masland, 1999; Sun, Li, & He, 2002; Badea & Nathans, 2004; Lin & Masland, 2006; V€ olgyi, Chheda, & Bloomfield, 2009 ). Other experimental approaches have been used to identify the entire cell population; for instance, immunostaining studies have identified welldefined bipolar and amacrine cell populations based on their neurochemical properties (Brecha et al., 1984; Voigt, 1986; Greferath, Gr€ unert, & Wässle, 1990; Vaney, 1990; Wässle, Puller, M€ uller, & Haverkamp, 2009) , and more recently mouse lines with genetic reporters have been used to identify bipolar, amacrine and ganglion cell populations (Gustincich, Feigenspan, Wu, Koopman, & Raviola, 1997; Huberman et al., 2009; Wässle et al., 2009; Kay et al., 2011a; Dhande, Stafford, Lim, & Huberman, 2015) . The identification of these cell types has proven to be advantageous for furthering the understanding of their roles in visual processing (M€ unch et al., 2009; Zhang, Kim, Sanes, & Meister, 2012; Dhande et al., 2013) .
Cre/lox recombination approaches have been highly useful for enabling genetic access to specific retinal cell populations to investigate their functional role in the retina and central nervous system (Lu, Ivanova, Ganjawala, & Pan, 2013; Duan, Krishnaswamy, De la Huerta, & Sanes, 2014; Lee et al., 2014; Gompf, Fuller, Hattar, Saper, & Lu, 2015) . This approach has become a valuable tool for untangling the diversity of amacrine cells and defining their synaptic relationships and connectivity, and their intrinsic and receptive field properties. For instance, recent studies have labeled Cre-expressing amacrine cells using either Cre-dependent reporter mouse lines or AAVs for anatomical characterization and electrophysiological studies of both the vGluT3-Cre and VIP-ires-Cre amacrine cells (Grimes, Seal, Oesch, Edwards, & Diamond, 2011; Lee et al., 2014; Zhu, Xu, Hauswirth, & DeVries, 2014; Akrouh & Kerschensteiner, 2015; Park et al., 2015) .
Cre-expressing amacrine cells can also be manipulated using optogenetic molecules to selectively stimulate or inhibit retinal cells and chemogenetic approaches (PSAM or DREADDs) to reversibly manipulate Cre-expressing retinal cell populations (Magnus et al., 2011; Madisen et al., 2012; Huang & Zeng, 2013; Sternson & Roth, 2014; Vlasits et al., 2014) .
This study has characterized Cre-expressing amacrine cells in a transgenic mouse line with Cre activity under the control of the vasoactive intestinal peptide (VIP) promoter (Taniguchi et al., 2011) . The majority of these cells, which contained VIP-and GABA-immunoreactivity were in the inner nuclear layer (INL). Cre-expressing cells mainly ramified in the ON sublayer of the IPL. In the INL, there was a wide-field, bistratified amacrine cell type and two medium-field amacrine cell types. A fourth medium-field amacrine cell type was in the GCL. These findings show that the VIP-ires-Cre and VIP-immunoreactive amacrine cells in the mouse retina (Tornqvist, Uddman, Sundler, & Ehinger, 1982; Cellerino, Arango-Gonzalez, Pinzon-Duarte, & Kohler, 2003; Zhu et al., 2014; Akrouh & Kerschensteiner, 2015; Park et al., 2015) consist of multiple amacrine cell types. The VIP-ires-Cre amacrine cells have distinct synaptic and receptive field properties (Akrouh & Kerschensteiner, 2015; Park et al., 2015) suggesting distinct functional roles in visual processing.
| MATERIALS A ND METHODS

| Animals and tissue preparation
Adult VIP-tdTomato and VIP-Confetti (Brainbow 2.1) mice of both sexes (20-30 g; <3-month old) were used for these studies. VIPtdTomato and -Confetti mice were generated by crossing a VIP-ires- reporter mouse line (Livet et al., 2007; Madisen et al., 2010; Taniguchi et al., 2011) (Jackson Laboratories, Bar Harbor, ME) 
| Immunohistochemical studies
For cryosections of the retina, the eyecups were immersion-fixed in 4% (w/v) paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB), pH 7.4, for 15-30 min, stored overnight in 30% sucrose, sectioned at 12-16 lm with a Leica cryostat (Leica Microsystems, Buffalo Grove, IL) and mounted onto gelatin-coated slides. Retinal sections were stored at 2208C. For whole-mounted retinas, the sclera was removed, the inferior retina was marked by a small radial cut in the peripheral retina, and the retina was flattened photoreceptor side down on black filter paper (EMD Millipore Corporation, Bedford, MA). The retina was subsequently immersion-fixed in 4% PFA in 0.1 M PB for 15 min. The whole-mounted retina was stored in 0.1 M PB until processing for immunohistochemistry.
| Intracellular dye injections studies
The retina was flattened with four radial cuts and mounted photoreceptor side down on black filter paper, transferred to a bicarbonatebuffered Ames medium (pH 7.4) that was bubbled continuously with carbogen (95% O 2 /5% CO 2 ) and mounted on a Zeiss Axioskop 2 for intracellular dye injections.
| Colchicine injections
Colchicine was injected into the vitreous (1 mg/ml) using a Hamilton syringe (Hamilton Robotics, Inc., Reno, NV) with a 30-gauge needle about 14 hr before euthanasia. The eyes were dissected and processed for immunohistochemistry as described above. Intraocular injections of colchicine increased neuropeptide immunostaining in the retina (Casini & Brecha, 1991) .
Chemicals used were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. (Table 1) 2.2.1 | Calretinin antibody A goat polyclonal antibody (cat# AB1550; EMD Millipore, Billerica, MA, RRID:AB_90764) against calretinin was generated against rat calretinin. Immunolabeling with the calretinin antibody revealed amacrine and displaced amacrine cells, retinal ganglion cells, and three distinct bands of processes in the IPL (Haverkamp & Wässle, 2000; Ghosh, Bujan, Haverkamp, Feigenspan, & Wässle, 2004) . The distal and proximal band of processes in the IPL overlap the choline acetyltransferase (ChAT)-immunoreactive processes in strata 2 and 4 of the IPL, and a third band of processes are in the center of the IPL, subdividing the IPL into the OFF and ON sublayers (Haverkamp & Wässle, 2000) . (Voigt, 1986; Jeon et al., 1998; Haverkamp & Wässle, 2000; Whitney, Keeley, Raven, & Reese, 2008; Haverkamp, Inta, Monyer, & Wässle, 2009 ).
| Antibody characterization
| GABA antibody
A rabbit polyclonal antibody (cat# A2052; Sigma-Aldrich, RRID: AB_477652) to GABA was generated against GABA conjugated to bovine serum albumin (BSA). The GABA antibody reacts with GABA and GABA-keyhole limpet hemocyanin conjugate in a dot blot assay, and it does not cross react with BSA (manufacturer's data sheet). The antibody has been used for identifying GABA-containing amacrine cells in the mouse retina (Haverkamp & Wässle, 2000; P erez de Sevilla M€ uller, Shelley, & Weiler, 2007; Dedek et al., 2009; Haverkamp et al., 2009 ).
| Glycine antibody
A rat polyclonal antibody (cat# IG1002; ImmunoSolution, Queensland, Australia, RRID: AB_10013222) to glycine was raised to a PFA conjugate of glycine and thyroglobulin (Pow, Wright, & Vaney, 1995) . The glycine antibody reacts with a glycine-BSA conjugate in a dot blot assay and antibody specificity was shown by elimination of immunoreactivity using the glycine-thyroglobulin conjugate used to immunize the animals (Pow et al., 1995) . This antibody immunostains amacrine cells in mice, rats, guinea pigs, and rabbits (Pow et al., 1995; Menger, Pow, & Wässle, 1998; Pow & Hendrickson, 1999; Rodriguez, de Sevilla Muller, & Brecha, 2014) .
| Green fluorescent protein (GFP) antibody
A rabbit polyclonal antibody (cat# AB3080P; EMD Millipore, Billerica, MA, RRID: AB_91338) to green fluorescent protein (GFP) was generated from highly purified Aequorea victoria (Teriakidis, Willshaw, & Ribchester, 2012; Simpson, Kita, Scott, & Goodhill, 2013) . The antibody reacts with GFP from both native and recombinant sources (manufacturer's technical information) and GFP immunostaining is absent in animals that do not express GFP (Schaefer, Sanes, & Lichtman, 2005 . The RBPMS antibody labeled a single band at 24 kDa on Western blots of mouse and rat retinal extracts corresponding to the expected molecular size of RBPMS. The affinity purified antibody was shown to exclusively immunostain ganglion cells in mouse and rat retina . No RBPMS immunostaining was present in tissues incubated with the RBPMS antibodies preabsorbed with RBPMS 4-24 peptide.
| Syntaxin 1A
In rabbit retina, both of these VIP antibodies labeled wide-field amacrine cells mainly located in the proximal INL and, occasionally in the GCL and IPL (Casini & Brecha, 1991) . In rat retina, a double label in situ hybridization and immunohistochemistry study showed co-localization of VIP mRNA and immunoreactivity in amacrine cells (Casini, Molnar, & Brecha, 1994) . In mouse and rat retina, other VIP antibodies immunostain amacrine cells with processes that are distributed to multiple strata in the IPL (Lor en, Tornqvist, & Alumets, 1980; Eriksen & Larsson, 1981; Tornqvist et al., 1982; Terubayashi et al., 1983; Herbst & Thier, 1996; Cellerino et al., 2003) .
| Vesicular acetylcholine transporter (VAChT)
A guinea pig affinity purified polyclonal antibody (cat# AB1588, EMD Millipore, Billerica, MA, RRID: AB_2187981) to VAChT was raised to the C-terminus of rat VAChT. This antibody detects a single band in rat brain homogenates corresponding to the predicted molecular size of rat VAChT and there was no staining of blots incubated with the antibody that had been preabsorbed with the peptide used for antibody production (manufacturer's technical information). VAChT antibodies immunostain the processes of cholinergic cells in the nervous system and starburst amacrine cells in strata 2 and 4 of the IPL in rat retina (Koulen, 1997; Wasselius, Johansson, Bruun, Zucker, & Ehinger, 1998; Sawaguchi et al., 1999) .
| Immunohistochemistry
Immunohistochemical labeling was performed using an indirect immunofluorescence method (Hirano et al., 2005) . Retinal sections were incu- Whole-mounted retinas were incubated in the same blocking solution as retinal sections overnight at 48C followed by incubation in primary antibodies ( 
| Analysis of whole-mounted retinas
Retinal whole-mounts were imaged in their entirety as tiled mosaics and "stitched" together with a 5% overlap at the edge of each optical section, using the Zeiss Zen 2011 Black software (version 3.2) package. Individual tiles were collected as 12-bit 3D z-stacks from the nerve fiber layer to the outer nuclear layer (ONL) using a 203/0.8NA objective and a zoom factor of 0.6. The confocal pinhole diameter was set to 1 Airy unit and pixel acquisition set to 512 3 512 to achieve an isotropic voxel of 1.38 mm 3
1.38 mm 3 1.38 mm while satisfying Nyquist sampling along all axes.
Mosaics of the tdTomato fluorescent cell bodies were analyzed using Fiji/ImageJ (Schindelin et al., 2012) . The retinal whole-mount boundary and optic nerve region were manually delineated. Mosaic images were preprocessed with a background subtraction using a rolling ball radius of 4 pixels and the edges detected as the gradient-magnitude image with 1 pixel smoothing using FeatureJ plugins http://imagescience.org/meijering/software/featurej/. Somata were segmented by thresholding the edge image with a Renyi Entropy algorithm followed by binary close, fillhole and watershed operations. Segmented objects with a mean intensity less than 25% of 12-bit max intensity, an aspect ratio greater than 5, or a coefficient of variation greater than 0.75 were rejected as noise. The image was visually inspected after processing and objects not corresponding to fluorescent somata were excluded from analysis. Additionally, objects with average diameters below 4 mm were excluded as noise; no upper limit was imposed. Cell locations were determined as the centroid coordinates of each segmented object. The area, perimeter, major/minor ellipse diameters, and Feret diameters of the tdTomato fluorescent cells were found. Cell diameter was calculated independently from area, 2ͱ A=p ð Þ, and perimeter, P=p, and then averaged with the measured major ellipse, minor ellipse, max Feret, and min Feret diameters. The weighted mean and weighted quartiles for somal diameter were calculated to determine somal size range, as well as mean and median somal size.
| R E S U LTS
| VIP-ires-Cre expression in the retina
To visualize VIP promoter-driven Cre activity in the retina, we crossed the VIP-ires-Cre mouse line (Taniguchi et al., 2011) with the Ai9 or the Ai14 Cre-dependent tdTomato reporter mouse line (Madisen et al., 2010) . In the retinas of both mouse lines, tdTomato fluorescence was robust, and the pattern of fluorescent cells in the INL and GCL were similar. The majority of studies used the Ai9 Cre-dependent tdTomato reporter mouse line.
In vertical sections and whole-mount retinas, tdTomato fluorescence was localized to small diameter ( In the INL, the fluorescent cell bodies were distributed to all retinal regions from the optic nerve head to the far peripheral retina. There were multiple examples of two and three fluorescent cell bodies that were located within 3 somal diameters (30 lm) of each other ( Figure   2 ). In addition, there were pairs of fluorescent cell bodies that were separated by 1 lm. There was a tendency for a higher frequency of cell pairs and triplets in the ventral retina, although this was not quantified. In the GCL, the majority of fluorescent cells were in a patch of the dorsal retina mid-way between the optic nerve head and the peripheral edge of the retina.
| Somal size of VIP-tdTomato fluorescent cells
The diameters of all fluorescent cell bodies in retinas from four VIP-iresCre::A9 tdTomato reporter mice were combined to determine their average and median size (Table 2; Figure 3 ). Somal diameters were estimated using four different approaches; assuming an elliptical fit, a somal diameter was calculated from the average length of its major and minor axis. A Feret diameter was calculated as the maximum distance between two parallel tangents to the cell. Cell diameters were also calculated from the cell area and perimeter. The estimates of somal diameter based on an ellipse, cell area, and cell perimeter were similar and slightly smaller (0.7 mm) than the Feret diameter. Individual somal diameters are an average of these four different somal diameter estimates.
Overall, fluorescent somata in the INL ranged from 4.40 to 18.07 mm in diameter and averaged 9.83 6 1.39 mm (N 5 4 retinas;
n 5 32,904 cells; mean 6 SD; Table 2 ; Figure 3a ). Somata in the GCL were similar in size with a range of 4.33-15.51 mm in diameter and averaged 8.77 6 1.14 mm (N 5 4 retinas; n 5 759 cells; mean 6 SD; 6 SD 8 6 pooled SD 1.14 Note. The ellipse diameter was calculated by averaging the length of the major and minor axis of the cell. Feret diameter was calculated as the maximum distance between two parallel tangents to the cell. Cell diameters based on cell area and perimeter were calculated from their respective values. The mean diameter is the average of the four calculated diameters and summarized as the weighted mean 6 the pooled standard deviation. N 5 VIPtdTomato cells.
In the INL, overall cell density was 534. The peak density of the cells in the GCL occurred in the dorsal retina at a mean eccentricity of 1.56 mm from the optic nerve head.
| Expression of amacrine cell markers in VIP-iresCre cells
General markers for amacrine cells, syntaxin 1A (HPC-1) a panamacrine cell marker (Barnstable et al., 1985) as well as GABA and glycine, which are expressed by most amacrine and displaced amacrine cells (Vaney, 1990; Strettoi & Masland, 1996; P erez de Sevilla M€ uller et al., 2007; Kay et al., 2011b) Retinal sections were also immunostained with antibodies to the pan-ganglion cell marker RBPMS , 1980; Eriksen & Larsson, 1981; Tornqvist et al., 1982; Terubayashi et al., 1983; Herbst & Thier, 1996; Cellerino et al., 2003) . VAChT-immunoreactive processes that are narrowly distributed to strata 2 and 4 of the IPL. Cell field sizes were calculated from the average of the major and minor axis of the field fitted to an ellipse. We defined narrow-field cells as having a field diameter of <125 mm, medium-field cells as having a field between 125 and 500 mm and wide-field cells as having a field >500 mm based on previous reports in the mouse retina (Badea & Nathans, 2004; P erez de Sevilla M€ uller et al., 2007; Dedek et al., 2009; Grimes et al., 2011; Pang, Gao, & Wu, 2012; Helmstaedter et al., 2013; Lee et al., 2014; Lee et al., 2015) .
These values are consistent with the definition of narrow-, medium-, and wide-field cells in the rabbit retina (MacNeil & Masland, 1998) . VAChT-immunoreactive (green) processes were distributed to strata 2 and 4 of the IPL. OPL 5 outer plexiform layer; INL 5 inner nuclear layer; GCL 5 ganglion cell layer; S1 5 stratum 1; S2 5 stratum 2; S3 5 stratum 3; S4 5 stratum 4; S5 5 stratum 5. Scale bar: 20 lm 1 *VIP-1, 22 and 23 amacrine cells were identified in a brief report on the VIP-ires-Cre cell types ; the VIP-1 bistratified amacrine cell type was called a VIP-2 amacrine cell, and the VIP-2 monostratified amacrine cell was called a VIP-1 amacrine cell in our original report . We have adopted in the current report the same nomenclature used in other studies ( , respectively. The average cell density in the INL and GCL is similar to findings in an earlier study also using the Ai9 reporter line (Madisen et al., 2010) to label VIP-ires-Cre amacrine cells (Akrouh & Kerschensteiner, 2015) and the cell density is slightly less than the VIP-ires-Cre cell density in VIP-ires-Cre lines crossed with either the Ai32 or Ai14 reporter line (Madisen et al., 2010; Madisen et al., 2012; Park et al., 2015) . The difference in these values may simply be due to retinal sampling, since we found the average VIP-tdTomato cell density to be higher in central and mid peripheral retina, and local regional differences could skew estimates of cell number and density. In addition, to sampling differences, other factors including age and phe- cell number and cell frequency that could occur by comparing cell number or average cell density between studies. These errors can be introduced by different tissue preparation and immunostaining protocols, sampling and counting errors as well as differences in the C57BL/6J strains, which have been shown to vary dramatically in different colonies (Williams, Strom, Rice, & Goldowitz, 1996; Jeon et al., 1998; Whitney et al., 2008; Keeley et al., 2014) . There is about an 8-fold lower number of VIP-tdTomato fluorescent amacrine cells compared to the number of AII amacrine cells (69,223 6 1,566; mean 6 SEM) and fewer VIP-tdTomato fluorescent amacrine cells compared to the vGluT3 amacrine cells (12,264 6 167; mean 6 SEM) (Keeley et al., 2014) . In comparison, the extensively studied dopamine-containing or tyrosine hydroxylase-immunoreactive amacrine cell population is much smaller with the number of cells estimated to range from 450 to 600 cells/ retina in the C57BL/6J mouse strain (Versaux-Botteri et al., 1984; Masland et al., 1993; Gustincich et al., 1997; Whitney et al., 2009; Keeley et al., 2014) . (Keeley et al., 2014) , and the recent report of 45 amacrine cell types in the mouse retina (Helmstaedter et al., 2013) there is likely to be a greater total number of amacrine cell types in the mammalian retina than estimated in earlier studies (Kolb et al., 1981; MacNeil & Masland, 1998; Masland, 2012b) .
| VIP amacrine cell types in the mouse retina
The VIP-1, 22A, 22B and 23 amacrine cell types were commonly (Park et al., 2015) . In contrast, tracer coupling was not detected for the VIP-2A, VIP-2B and VIP-3 amacrine cells. The VIP-1 amacrine cell resembles the "Type 40, ac16-76" (Helmstaedter et al., 2013 ) amacrine cell in mouse retina. The VIP-1 amacrine cell is the same cell type as the "VIP-1" amacrine cell identified using a Cre-dependent AAV-GFP sparse labeling or a Cre-dependent AAV-Brainbow labeling strategy (Zhu et al., 2014; Akrouh & Kerschensteiner, 2015) , and the "bistratified INL cell" intracellularly labeled with Lucifer yellow in the VIPires-Cre mouse line (Park et al., 2015) . VIP-2A amacrine cells have a similar appearance to "cluster 1" (Badea & Nathans, 2004) and the "Type 48, ac51-66" (Helmstaedter et al., 2013) amacrine cells in the mouse retina. They are members of the "VIP-2" amacrine cells (see fig. 2C in Akrouh & Kerschensteiner, 2015) and the "narrow-field INL" cell group in the VIP-ires-Cre line (Park et al., 2015) . These amacrine cells were designated as a "narrow-field"
amacrine cell in an earlier study (Park et al., 2015) , although they do not meet the classical definition of a narrow-field cell (MacNeil & Masland, 1998; Menger & Wässle, 2000; Pang et al., 2012) based on the size of their fields, and their expression of GABA-and not glycineimmunoreactivity (Vaney, 1990) . We have classified these cells as medium-field amacrine cells. amacrine cells also appear similar to "cluster 1" (Badea & Nathans, 2004) and "Type 50, ac54-67" (Helmstaedter et al., 2013) This is the same cell type as the "VIP-3" amacrine cell and the "mono- VIP-ires-Cre connectivity with ganglion cells is better understood (Park et al., 2015) . The delta, ON-OFF directional selective, and the W3 ganglion cells receive a strong channelrhodopsin2 (ChR2)-evoked inhibitory input from VIP-ires-Cre amacrine cells, and their inhibitory response was blocked by the GABA A antagonist SR95531 consistent with VIP-ires-Cre amacrine cells having a GABA-mediated inhibitory presynaptic action in these circuits (Park et al., 2015) . These findings match the dendritic stratification of these ganglion cells (Peichl, 1989; Huberman et al., 2009; Kim, Zhang, Meister, & Sanes, 2010) VIP amacrine cells in the mouse retina are also likely to be presynaptic and postsynaptic to other amacrine cells based on general observations of mammalian IPL connectivity (Anderson et al., 2011) and VIP immunostaining in the IPL of the guinea pig and rabbit retina (Pachter, Marshak, Lam, & Fry, 1989; Lee et al., 2002) . Furthermore, GABA A and glycine receptor antagonists block inhibitory responses of VIP-ires-Cre amacrine cells consistent with amacrine cell input to these cells (Park et al., 2015) . The VIP-1 amacrine cells, but not the other VIP amacrine cell types are also homotypically and heterotypically gap-coupled to amacrine cells in the INL and GCL (Park et al., 2015) .
| VIP amacrine cells in the mammalian retina
VIP-immunoreactive amacrine cells occur in the retinas of many mammalian orders, including primates (Tornqvist et al., 1982; Stone, Laties, Raviola, & Wiesel, 1988; Tornqvist & Ehinger, 1988; Marshak, 1989; Li & Lam, 1990; Lammerding-Koppel, Thier, & Koehler, 1991) , lagomorphs (Sagar, 1987; Casini & Brecha, 1991) , and rodents (Lor en et al., 1980; Eriksen & Larsson, 1981; Tornqvist et al., 1982; Terubayashi et al., 1983; Casini et al., 1994; Lee et al., 2002; Cellerino et al., 2003) .
VIP amacrine cells are usually described as sparsely distributed, widefield amacrine cells. Guinea pig, rabbit, and monkey retina have one or two wide-field VIP-immunoreactive amacrine cell types and their population is characterized by a low density across the retina (Casini & Brecha, 1991; Lammerding-Koppel et al., 1991; Lee et al., 2002) . In contrast, in the mouse retina there are multiple VIP-ires-Cre amacrine cell types, and their density in the INL is considerably higher than the density of the VIP-immunoreactive amacrine cells in these other species. The morphology of the VIP-ires-Cre amacrine cell types in mouse retina also differs from the descriptions of VIP-immunoreactive cell types in other species. These differences in the VIP amacrine cell population are an exception to general findings that amacrine cells with similar phenotypic morphological features are found in multiple mammalian species. For example, the well-studied AII, A17, ChAT, vGluT3, and TH amacrine cells have similar morphologies and physiological properties in different species including the mouse, rat, cat, rabbit, and monkey (Famiglietti & Kolb, 1975; Famiglietti, 1983; Ballesta, Terenghi, Thibault, & Polak, 1984; Brecha et al., 1984; Versaux-Botteri et al., 1984; Nelson & Kolb, 1985; Voigt, 1986; Wulle & Wagner, 1990; Rodieck, 1991; Rodieck & Marshak, 1992; Masland et al., 1993; Casini et al., 1995; Gustincich et al., 1997; Menger et al., 1998; Haverkamp & Wäs-sle, 2000; Menger & Wässle, 2000; . 
| VIP and GABA co-expression
The finding of tdTomato fluorescent cells with GABA immunoreactivity is consistent with earlier observations of VIP-immunoreactive (Casini & Brecha, 1992; Lee et al., 2002) and VIP-tdTomato fluorescent cells (Zhu et al., 2014; Park et al., 2015) expressing GABA or the GABA synthesizing enzyme, L-glutamate decarboxylase (GAD) immunoreactivity.
The expression of GABA and GAD in VIP-ires-Cre amacrine cells is also consistent with other studies showing the expression of GABA in medium-and wide-field amacrine cells (Brecha, Johnson, Peichl, & Wässle, 1988; Wässle & Chun, 1988; Vaney, Whitington, & Young, 1989; Vaney, 1990; Wulle & Wagner, 1990) . GABA released from VIP amacrine cells would mediate a fast inhibitory action of VIP-ires-Cre cells at synaptically connected cells.
GABA's action is also potentiated by VIP; VIP increases GABAinduced chloride currents (Veruki & Yeh, 1992) and it stimulates adenylate cyclase and phosphorylation of GABA A receptors in isolated bipolar and ganglion cells, and amacrine cells in retinal slice cultures (Feigenspan & Bormann, 1994; Veruki & Yeh, 1994) . VIP modulation of GABA A receptors, which are widespread in both the inner and outer retina (Brecha, 1992; Wässle, Koulen, Brandstätter, Fletcher, & Becker, 1998; Zhang & McCall, 2012) could be a cellular mechanism for VIP mediating a broad modulatory influence on visual processing in the retina.
VIP could also interact with other transmitter signaling systems, including dopamine-receptive cells though co-regulation of a shared cAMP pool (Pachter & Lam, 1986; Jensen, 1993) . For instance, VIP regulation of cAMP levels and phosphorylation states could influence gap junction permeability, as reported for dopamine and the regulation of AII amacrine cell junctions (Hampson, Vaney, & Weiler, 1992; Massey & Mills, 1999; Urschel et al., 2006; Kothmann, Massey, & O'brien, 2009 ). Although less studied, the neuroactive peptide, peptide histidine isoleucine (PHI), which is derived from a single preprovasoactive intestinal polypeptide precursor (Itoh, Obata, Yanaihara, & Okamoto, 1983) and encoded by a single VIP/PHI mRNA (Linder et al., 1987) may also influence visual processing in the retina. In support of this possibility is the co-expression of PHI and VIP immunoreactivity and mRNA in amacrine cells (Mikkelsen, Larsen, Fahrenkrug, & Møller, 1987; Pachter et al., 1989; Casini et al., 1994) and PHI stimulation of adenylate cyclase activity and cAMP formation in rabbit retina (Schorderet, Hof, & Magistretti, 1984; Pachter et al., 1989) .
As a dual or perhaps a tri-transmitter amacrine cell, the release of GABA by VIP amacrine cells would act at synaptically connected cells within the IPL (Akrouh & Kerschensteiner, 2015; Park et al., 2015) , and the neuropeptides, VIP and PHI would act more broadly on multiple retinal cells across the retina. The factors mediating GABA and neuropeptide release from the VIP amacrine cells are likely to differ, based on earlier studies that the stimulus conditions for fast amino acid transmitter release from neurons differ from those for neuropeptides, which are released by a high frequency and long duration stimulus (Jackson, Konnerth, & Augustine, 1991; Muschol & Salzberg, 2000) . The release of neuropeptides following evoked stimulation is slower than the fast amino acids (Martin, 2003) and their cellular action, including VIP in the retina, are also slower than fast amino acid transmitters, since VIP activates G-proteins and intracellular signaling pathways to influence neuronal activity (Dickson & Finlayson, 2009; van den Pol, 2012) . (Zhu et al., 2014; Vuong, Perez de Sevilla Muller, Hardi, McMahon, & Brecha, 2015) . Striking examples are the expression of Cre in multiple amacrine and ganglion cell types in the somatostatin-IRES-Cre (Zhu et al., 2014) and several of the TH-Cre and TH-BAC-Cre lines (Vuong et al., 2015) .
One explanation for the failure of previous studies to rigorously define VIP amacrine cell types in the mouse and rat retina is the difficulty of characterizing these cells using immunohistochemistry (Lor en et al., 1980; Eriksen & Larsson, 1981; Terubayashi et al., 1982 Terubayashi et al., , 1983 Tornqvist et al., 1982; Kondo, Kuramoto, Wainer, & Yanaihara, 1985; Cellerino et al., 2003) . This is due to multiple factors, including differences in primary antibody specificity and titer, extensive overlap of immunoreactive processes making it difficult to parse out single cell types and variability in detectable levels of VIP immunoreactivity due to environmental or intrinsic factors (Eriksen & Larsson, 1981; Cellerino et al., 2003) . Factors that influence the level of VIP immunoreactivity in amacrine cells include (1) light, which has been shown to regulate VIP mRNA expression during the second half of a 12-hr light period (Brand, Burkhardt, Schaeffel, Choi, & Feldkaemper, 2005) and VIP immunoreactivity (Eriksen & Larsson, 1981; Stone et al., 1988; Herbst & Thier, 1996) , and (2) BDNF, which influences the levels of VIP immunoreactivity in VIP amacrine cells in the mouse and rat retina (Cellerino et al., 2003) . Difficulties in demonstrating the morphology of VIPimmunoreactive amacrine cells in the mouse and rat retina is consistent with our observation that there is considerable variation in the strength of VIP immunostaining in amacrine cells of both wild type and VIPtdTomato mouse retinas. The present study found that VIP-tdTomato fluorescent amacrine cells contained VIP immunoreactivity. To check for VIP-immunoreactive cells that do not express Cre, the eyes of the VIP-tdTomato mice were treated intravitreally with colchicine to enhance the detectability of VIP immunoreactivity (Casini & Brecha, 1991) . In these experiments, VIP immunostaining in the tdTomato fluorescent somata was increased; fluorescent cells contained VIP immunoreactivity, and no additional VIP-immunoreactive amacrine cells were revealed in the treated retinas. These findings further support the idea that Cre is expressed in VIP-expressing amacrine cells.
In summary, the majority of Cre-expressing cells in the VIP-iresCre transgenic mouse line (Taniguchi et al., 2011) 
